Who has invested in Xgene Pharmaceutical?

No investors are named on the public record for Xgene Pharmaceutical yet.

Xgene Pharmaceutical Funding: $60M Raised, Series C (2021)

Xgene Pharmaceutical funding overview

Xgene Pharmaceutical is based in Taiwan. Xgene Pharmaceutical has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in November 2021. The round record for Xgene Pharmaceutical runs through 2021; nothing later has been disclosed.

Xgene Pharmaceutical at a glance

Total raised: $60M
Latest round: Series C
Latest round date: November 2021
Headquarters: Taiwan

Frequently asked about Xgene Pharmaceutical funding

How much has Xgene Pharmaceutical raised?: Xgene Pharmaceutical has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Xgene Pharmaceutical?: No investors are named on the public record for Xgene Pharmaceutical yet.
What was the latest Xgene Pharmaceutical funding round?: The most recent disclosed round is a Series C, announced in November 2021.
Where is Xgene Pharmaceutical based?: Xgene Pharmaceutical is based in Taiwan.
When did Xgene Pharmaceutical last raise?: The last disclosed Xgene Pharmaceutical round closed in November 2021 at Series C.

We update the Xgene Pharmaceutical record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Taiwan and their backers are listed below.

Xgene Pharmaceutical Funding: $60M Raised, Series C (2021)

Xgene Pharmaceutical funding overview

Xgene Pharmaceutical at a glance

Frequently asked about Xgene Pharmaceutical funding

Companies related to Xgene Pharmaceutical (18)

Browse related funding lists (3)